Inhibition by dipyridamole of neutrophil adhesion to vascular endothelium during coronary bypass surgery.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Annals of Thoracic Surgery

• Publication date

  1999-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0003-4975(99)00173-3PMID 10355396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations

  1997influential reference
• Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease.

  1996cited by this paper
• Effect of adenosine on the expression of β2 integrins and L‐selectin of human polymorphonuclear leukocytes in vitro

  1996cited by this paper
• Inflammatory Cascade: A Final Common Pathway for Perioperative Injury?

  1996cited by this paper
• CD18-independent mechanism of neutrophil emigration in the rabbit lung after ischemia-reperfusion.

  1995cited by this paper
• Clinical Investigations: Cardiopulmonary BypassAcute Lung Injury During Cardiopulmonary Bypass: Are the Neutrophils Responsible?

  1995cited by this paper
• Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes.

  1995cited by this paper
• Adhesion molecules and inflammatory injury

  1994cited by this paper
• Leukocyte-endothelial adhesion molecules.

  1994cited by this paper
• Acting via A2 receptors, adenosine inhibits the upregulation of Mac-1 (Cd11b/CD18) expression on FMLP-stimulated neutrophils.

  1993cited by this paper
• Protective Effects of Adenosine In Myocardial Ischemia

  1992cited by this paper
• Inhibition of active oxygen generation by dipyridamole in human polymorphonuclear leukocytes.

  1992cited by this paper
• Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors.

  1992cited by this paper
• Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: adenosine-dependent and adenosine-independent mechanisms.

  1991cited by this paper
• Nitric oxide: an endogenous modulator of leukocyte adhesion.

  1991cited by this paper
• Transient adhesion of neutrophils to endothelium

  1989cited by this paper
• Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass.

  1988cited by this paper
• Dipyridamole Inhibits Superoxide Anion Generation by Human Neutrophils

  1988cited by this paper
• Neutrophil adherence to human endothelium in vitro occurs by CDw18 (Mo1, MAC-1/LFA-1/GP 150,95) glycoprotein-dependent and -independent mechanisms.

  1988cited by this paper
• Fibrinolytic and Haemostatic Responses to Desamino-D-Arginine Vasopressin (DDAVP) Administered by Intravenous and Subcutaneous Routes in Healthy Subjects

  1988cited by this paper
• Dipyridamole.

  1987cited by this paper
• Dipyridamole reduced myocardial platelet and leukocyte deposition following ischemia and cardioplegia.

  1987cited by this paper
• Drug therapy. Dipyrimadole

  1987cited by this paper
• Biology of Endothelial Cells

  1984cited by this paper
• Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosine.

  1984cited by this paper
• A Comparison of Spontaneous Platelet Aggregation in Whole Blood with Platelet Rich Plasma: Additional Evidence for the Role of ADP

  1984cited by this paper
• Culture and identification of large vessel endothelial cells

  1984cited by this paper
• Adenosine: a physiological modulator of superoxide anion generation by human neutrophils

  1983cited by this paper
• Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients.

  1981cited by this paper
• Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: possible explanation of mechansim of inhibition of platelet function.

  1975cited by this paper

• Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole

  2020cites this paper
• Phosphodiesterase Inhibitors

  2019cites this paper
• The neuron‐astrocyte‐microglia triad in CA3 after chronic cerebral hypoperfusion in the rat: Protective effect of dipyridamole

  2017cites this paper
• Nephroprotective role of dipyridamole in diabetic nephropathy: Effect on inflammation and apoptosis.

  2015cites this paper
• Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis

  2015cites this paper
• Dipyridamole: a drug with unrecognized antioxidant activity.

  2015cites this paper
• The role of the Toll-like receptors in systemic inflammatory response to cardiac surgery

  2015cites this paper
• The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: protective effect of dipyridamole

  2014cites this paper
• Potential for Developing Purinergic Drugs for Gastrointestinal Diseases

  2014cites this paper
• Treatment with dipyridamole improves cardiac function and prevent injury in a rat model of hemorrhage.

  2012cites this paper
• Dipyridamole augments the antiinflammatory response during human endotoxemia

  2011cites this paper
• Effect of intravenous administration of dipyridamole in a rat model of chronic cerebral ischemia

  2010cites this paper
• Adenosine transport, erythrocyte deformability and microvascular dysfunction: An unrecognized potential role for dipyridamole therapy

  2010cites this paper
• Targeting the Inflammatory Response in Secondary Stroke Prevention: A Role for Combining Aspirin and Extended-release Dipyridamole

  2009cites this paper
• Dipyridamole, cerebrovascular disease, and the vasculature.

  2008cites this paper
• Dipyridamole enhances inhibitory effect of adenosine on neutrophils in human peripheral blood

  2008cites this paper
• Modification of neutrophil adhesion to human endothelial cell line in acute ischemic stroke by dipyridamole and candesartan

  2007cites this paper
• New roles for an old drug: inhibition of gene expression by dipyridamole in platelet-leukocyte aggregates.

  2006cites this paper
• Simvastatin attenuates leucocyte–endothelial interactions after coronary revascularisation with cardiopulmonary bypass

  2003cites this paper
• Inhibition of systemic inflammatory response with sodium nitroprusside in open heart surgery.

  2002cites this paper